Ziopharm Oncology

$3.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-2.77%) Today
-$0.04 (-1.20%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ZIOP and other stocks, options, and ETFs commission-free!

About ZIOP

ZIOPHARM Oncology Inc Common Stock, also called Ziopharm Oncology, is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T.

CEO
Heidi M. Hagen
Employees
106
Headquarters
Boston, Massachusetts
Founded
2003
Market Cap
677.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.48M
High Today
$3.47
Low Today
$3.28
Open Price
$3.47
Volume
1.16M
52 Week High
$5.95
52 Week Low
$2.06

ZIOP Earnings

-$0.63
-$0.42
-$0.21
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

ABIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure